Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kari L Ring

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Cancer|September 27, 2024
Two birds, one stone? The risks and benefits of combined prenatal carrier screening and hereditary cancer screeningKari L Ring
JAMA Surgery|August 14, 2024
The Intersection of Endometriosis and Ovarian Cancer PreventionKari L Ring
Current Treatment Options in Oncology|November 7, 2018
The Role of PD-1 Checkpoint Inhibition in Gynecologic MalignanciesChristine Garcia, Kari L Ring
Gynecologic Oncology|March 31, 2015
One size may not fit all: the debate of universal tumor testing for Lynch syndromeKaren H Lu, Kari L Ring
Frontiers in Oncology|March 20, 2023
Updates in gynecologic care for individuals with lynch syndromeKaylee A Underkofler, Kari L Ring
Gynecologic Oncology|January 25, 2024
How far is too far? Cancer prevention and clinical trial enrollment in geographically underserved patient populationsKari L Ring, Linda R Duska
Obstetrics and Gynecology Clinics of North America|February 12, 2018
Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk ReductionKari L Ring, Susan C Modesitt
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 31, 2019
TIM-3 in endometrial carcinomas: an immunotherapeutic target expressed by mismatch repair-deficient and intact cancersMargaret Moore, Kari L Ring, Anne M Mills
Gynecologic Oncology Reports|June 13, 2018
PD-L1 pitfalls: Emphasizing the importance of membranous localization and correlation with tumor cell and macrophage distributionsAnne M Mills, Chelsea Gottlieb, Kari L Ring
Cancer Journal (Sudbury, Mass.)|April 26, 2016
Immune Checkpoint Inhibitors in the Treatment of Gynecologic MalignanciesKari L Ring, Janelle Pakish, Amir A Jazaeri
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Cancer|September 27, 2024
Two birds, one stone? The risks and benefits of combined prenatal carrier screening and hereditary cancer screeningKari L Ring
JAMA Surgery|August 14, 2024
The Intersection of Endometriosis and Ovarian Cancer PreventionKari L Ring
Current Treatment Options in Oncology|November 7, 2018
The Role of PD-1 Checkpoint Inhibition in Gynecologic MalignanciesChristine Garcia, Kari L Ring
Gynecologic Oncology|March 31, 2015
One size may not fit all: the debate of universal tumor testing for Lynch syndromeKaren H Lu, Kari L Ring
Frontiers in Oncology|March 20, 2023
Updates in gynecologic care for individuals with lynch syndromeKaylee A Underkofler, Kari L Ring
Gynecologic Oncology|January 25, 2024
How far is too far? Cancer prevention and clinical trial enrollment in geographically underserved patient populationsKari L Ring, Linda R Duska
Obstetrics and Gynecology Clinics of North America|February 12, 2018
Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk ReductionKari L Ring, Susan C Modesitt
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 31, 2019
TIM-3 in endometrial carcinomas: an immunotherapeutic target expressed by mismatch repair-deficient and intact cancersMargaret Moore, Kari L Ring, Anne M Mills
Gynecologic Oncology Reports|June 13, 2018
PD-L1 pitfalls: Emphasizing the importance of membranous localization and correlation with tumor cell and macrophage distributionsAnne M Mills, Chelsea Gottlieb, Kari L Ring
Cancer Journal (Sudbury, Mass.)|April 26, 2016
Immune Checkpoint Inhibitors in the Treatment of Gynecologic MalignanciesKari L Ring, Janelle Pakish, Amir A Jazaeri
Pageof 6